BioStock: Stayble Therapeutics wants to offer better treatment for patients with back pain

Stayble Therapeutics is developing an injection treatment, STA363, to remedy the intense back pain that occurs in patients with discogenic back pain. Unlike today’s treatment options, STA363 treats the underlying causes of the pain. But how many people suffer from discogenic back pain and how can Stayble Therapeutics fill the therapeutic need?

Read the full article at biostock.se:

https://www.biostock.se/en/stayble-therapeutics-wants-to-offer-better-treatment-for-patients-with-back-pain/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se